Posted on May 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on March 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on March 2, 20223/2/22
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
Posted on January 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on January 20, 20221/20/22
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Posted on January 14, 20221/14/22
A Partnership Q&A with EVERSANA and Shorla Pharma
Posted on January 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on December 22, 202112/22/21